首页> Neuro-oncology> Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.

Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.

导出 LinkOut

翻译打印收藏纠错

第一作者： Johannes,Gojo

第一单位： Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria; Neuromed Campus, Kepler University Hospital, Linz, Austria; Institute of Neurology, Medical University of Vienna, Austria; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, University Hospital Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurosurgery, Medical University of Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Austria.

作者： Johannes,Gojo ^[1] ; Daniela,Lötsch ^[1] ; Sabine,Spiegl-Kreinecker ^[1] ; Kristian W,Pajtler ^[1] ; Katharina,Neumayer ^[1] ; Pia,Korbel ^[1] ; Asuka,Araki ^[1] ; Anita,Brandstetter ^[1] ; Thomas,Mohr ^[1] ; Volker,Hovestadt ^[1] ; Lukas,Chavez ^[1] ; Dominik,Kirchhofer ^[1] ; Gerda,Ricken ^[1] ; Harald,Stefanits ^[1] ; Andrey,Korshunov ^[1] ; Stefan M,Pfister ^[1] ; Karin,Dieckmann ^[1] ; Amedeo A,Azizi ^[1] ; Thomas,Czech ^[1] ; Martin,Filipits ^[1] ; Marcel,Kool ^[1] ; Andreas,Peyrl ^[1] ; Irene,Slavc ^[1] ; Walter,Berger ^[1] ; Christine,Haberler ^[1]

作者单位： Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria; Neuromed Campus, Kepler University Hospital, Linz, Austria; Institute of Neurology, Medical University of Vienna, Austria; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, University Hospital Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurosurgery, Medical University of Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Austria. ^[1]

关键词 RelA fusion chromosome 1q ependymoma promoter methylation telomerase